We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Morphosys AG | TG:MOR | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|
| -0.70 | -1.03% | 66.95 | 22,893 | 22:50:02 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 66.70 | 67.20 | 68.00 | 66.75 | 67.90 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 238.28M | -189.73M | -5.0387 | -14.17 | 2.69B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 20:42:47 | 220 | 66.90 | EUR |
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/11/2023 | 22:19 | DJN | MorphoSys Trial for Blood-Cancer Treatment Reaches Primary Endpoint |
Morphosys (MOR) Share Charts1 Year Morphosys Chart |
|
1 Month Morphosys Chart |
Intraday Morphosys Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
